Consistent with this, increased expression of the major glucose transporter in cancer cells, glucose transporter 1 (GLUT1) (also known as SLC2A1), has been associated with increased proliferation and consequent poor prognosis [49]. This evidence concerns the gene SLC2A1 and cancer.